0 CHECKOUT

Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2015

  • ID: 3275751
  • May 2015
  • 43 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Beech Tree Labs, Inc.
  • Mymetics Corporation
  • NanoViricides, Inc.
  • Onxeo SA
  • Spider Biotech
  • MORE

Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2015

Summary

The‘Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2015’, provides an overview of the Herpes Labialis (Oral Herpes)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Herpes Labialis (Oral Herpes), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Herpes Labialis (Oral Herpes) and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Beech Tree Labs, Inc.
  • Mymetics Corporation
  • NanoViricides, Inc.
  • Onxeo SA
  • Spider Biotech
  • MORE

List of Tables

List of Figures

Introduction

Report Coverage

Herpes Labialis (Oral Herpes) Overview

Therapeutics Development

Pipeline Products for Herpes Labialis (Oral Herpes) - Overview

Pipeline Products for Herpes Labialis (Oral Herpes) - Comparative Analysis

Herpes Labialis (Oral Herpes) - Therapeutics under Development by Companies

Herpes Labialis (Oral Herpes) - Pipeline Products Glance

Late Stage Products

Clinical Stage Products

Early Stage Products

Herpes Labialis (Oral Herpes) - Products under Development by Companies

Herpes Labialis (Oral Herpes) - Companies Involved in Therapeutics Development

Beech Tree Labs, Inc.

Foamix Pharmaceuticals Ltd.

Mymetics Corporation

NanoViricides, Inc.

Onxeo SA

Spider Biotech

Herpes Labialis (Oral Herpes) - Therapeutics Assessment

Assessment by Monotherapy Products

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Drug Profiles

acyclovir - Drug Profile

Product Description

Mechanism of Action

R&D Progress

acyclovir - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Aspidasept - Drug Profile

Product Description

Mechanism of Action

R&D Progress

BTL-TMLHSV - Drug Profile

Product Description

Mechanism of Action

R&D Progress

HerpeCide-I - Drug Profile

Product Description

Mechanism of Action

R&D Progress

herpes simplex virus [type 1, 2] vaccine - Drug Profile

Product Description

Mechanism of Action

R&D Progress

SB-105A10 - Drug Profile

Product Description

Mechanism of Action

R&D Progress

Herpes Labialis (Oral Herpes) - Recent Pipeline Updates

Herpes Labialis (Oral Herpes) - Dormant Projects

Herpes Labialis (Oral Herpes) - Discontinued Products

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Number of Products under Development for Herpes Labialis (Oral Herpes), H1 2015

Number of Products under Development for Herpes Labialis (Oral Herpes) - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Comparative Analysis by Late Stage Development, H1 2015

Comparative Analysis by Clinical Stage Development, H1 2015

Comparative Analysis by Early Stage Development, H1 2015

Products under Development by Companies, H1 2015

Herpes Labialis (Oral Herpes) - Pipeline by Beech Tree Labs, Inc., H1 2015

Herpes Labialis (Oral Herpes) - Pipeline by Foamix Pharmaceuticals Ltd., H1 2015

Herpes Labialis (Oral Herpes) - Pipeline by Mymetics Corporation, H1 2015

Herpes Labialis (Oral Herpes) - Pipeline by NanoViricides, Inc., H1 2015

Herpes Labialis (Oral Herpes) - Pipeline by Onxeo SA, H1 2015

Herpes Labialis (Oral Herpes) - Pipeline by Spider Biotech, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Stage and Target, H1 2015

Number of Products by Stage and Mechanism of Action, H1 2015

Number of Products by Stage and Route of Administration, H1 2015

Number of Products by Stage and Molecule Type, H1 2015

Herpes Labialis (Oral Herpes) Therapeutics - Recent Pipeline Updates, H1 2015

Herpes Labialis (Oral Herpes) - Dormant Projects, H1 2015

Herpes Labialis (Oral Herpes) - Discontinued Products, H1 2015

List of Figures:

Number of Products under Development for Herpes Labialis (Oral Herpes), H1 2015

Number of Products under Development for Herpes Labialis (Oral Herpes) - Comparative Analysis, H1 2015

Number of Products under Development by Companies, H1 2015

Comparative Analysis by Early Stage Products, H1 2015

Assessment by Monotherapy Products, H1 2015

Number of Products by Top 10 Targets, H1 2015

Number of Products by Stage and Top 10 Targets, H1 2015

Number of Products by Top 10 Mechanism of Actions, H1 2015

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015

Number of Products by Top 10 Routes of Administration, H1 2015

Number of Products by Stage and Top 10 Routes of Administration, H1 2015

Number of Products by Top 10 Molecule Types, H1 2015

Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

- Beech Tree Labs, Inc.
- Foamix Pharmaceuticals Ltd.
- Mymetics Corporation
- NanoViricides, Inc.
- Onxeo SA
- Spider Biotech

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Maquet Getinge Group
  • Emergent BioSolutions, Inc.
  • Aicuris GmbH & Co.KG
  • Merck & Co., Inc.